Clinical Trials

Breast Neoplasms

NCT04316117 2026-05-05

Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study

138 enrolled

Breast Neoplasms

NCT00802711 2026-04-13

3-Dimensional Conformal Radiation Therapy or Internal Radiation Therapy After Breast-Conserving Surgery in Treating Women With Stage I or Stage II Breast Cancer

Phase NA Terminated

6 enrolled

Breast Neoplasms, Carcinoma, Ductal, Breast

NCT02630693 2026-04-13

Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer

180 enrolled 14 charts

Breast Neoplasms

NCT04650581 2026-04-13

FINER

250 enrolled 13 charts

Breast Neoplasms

NCT00003140 2026-03-27

Letrozole After Tamoxifen in Treating Women With Breast Cancer

5,187 enrolled

Breast Neoplasms

NCT00066443 2026-03-27

Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer

Phase 1/2 Completed

93 enrolled

Phase 1/2 Active not recruiting

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT03568422 2026-03-27

CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer

37 enrolled 14 charts

Breast Neoplasms

NCT01349322 2026-03-05

Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery

2,354 enrolled 29 charts

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT05896566 2026-02-24

PREcoopERA

231 enrolled

Breast Neoplasms

NCT07425002 2026-02-20

PRISM

1,600 enrolled

Breast Neoplasms

NCT04176848 2026-02-18

CFI-400945 and Durvalumab in Patients With Advanced Triple Negative Breast Cancer

15 enrolled 7 charts

Breast Neoplasms

NCT01674140 2026-02-10

e3

1,939 enrolled 15 charts

Phase NA Active not recruiting

Breast Neoplasms, Breast Neoplasms, Male

NCT02308085 2026-02-09

POSITIVE

518 enrolled

Breast Neoplasms

NCT00066690 2026-02-06

SOFT

3,066 enrolled 15 charts

Breast Neoplasms

NCT00066703 2026-02-06

TEXT

2,672 enrolled 14 charts

Breast Neoplasms

NCT03624543 2026-01-30

CFI-400945 in Patients With Advanced/Metastatic Breast Cancer

51 enrolled

Breast Neoplasms

NCT06995443 2026-01-30

REGAIN

200 enrolled

Breast Neoplasms, Neoplasms, Cognitive Dysfunction

NCT07084558 2025-10-28

TEODOR

350 enrolled

Breast Neoplasms

NCT03418961 2025-10-08

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Phase 3 Recruiting

491 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms, Cardiotoxicity

NCT03283384 2025-09-19

NEOLBC

100 enrolled

Breast Neoplasms

NCT03820063 2025-09-19

TRAIN-3

462 enrolled

Breast Neoplasms

NCT01766297 2025-09-09

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

Phase 2 Recruiting

132 enrolled

Breast Neoplasms

NCT05856773 2025-09-09

COMPRO

Phase 3 Recruiting

276 enrolled

Breast Neoplasms

NCT01758445 2025-09-04

Proton Radiation for Stage II/III Breast Cancer

220 enrolled

Breast Neoplasms, Neoplasms

NCT06462963 2025-08-01

SPRINT

BreastGastrointestinalGenitourinary

302 enrolled

Breast Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT00070564 2025-07-31

S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer

3,294 enrolled 22 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT04042051 2025-07-22

Panthera

Phase 1 Terminated

2 enrolled

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT00963417 2025-07-14

TEXT-Bone

Phase NA Completed

119 enrolled

Phase NA Active not recruiting

Breast Neoplasms, Osteoporosis

NCT01824836 2025-05-31

A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)

1,046 enrolled 15 charts

Breast Neoplasms

NCT01526369 2025-05-09

TH V THL

75 enrolled

Breast Neoplasms

NCT03644186 2024-12-13

TOUCH

147 enrolled 11 charts

Phase 3 Not yet recruiting

Breast Neoplasms

NCT06407401 2024-11-05

Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer

399 enrolled

Breast Neoplasms, Musculoskeletal Pain, Drug-Related Side Effects and Adverse Reactions

NCT00365105 2024-09-20

Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer

BreastGenitourinaryThoracic

261 enrolled 12 charts

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Pain, Prostatic Neoplasms

NCT01015625 2024-08-19

POSYTIVE

Phase NA Completed

90 enrolled 16 charts

Breast Neoplasms, Neoplastic Cells, Circulating

NCT01564368 2024-04-15

ACRIN6698

Phase NA Completed

406 enrolled 11 charts

Breast Neoplasms

NCT00382070 2024-03-22

Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer

Phase 3 Unknown

3,966 enrolled 12 charts

Breast Neoplasms

NCT00003782 2024-03-21

Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes

5,351 enrolled 8 charts

Breast Neoplasms

NCT00295646 2024-03-15

Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid

1,803 enrolled 20 charts

Breast Neoplasms

NCT00036868 2024-03-08

Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer

90 enrolled

Breast Neoplasms

NCT00424164 2024-03-08

LAPATAM

Phase 1 Completed

20 enrolled